Last updated: July 13, 2026
The clinical case for remote cardiac monitoring already spans large, diverse patient populations. A 2026 meta-analysis by Scholte et al. analyzing 79 randomized controlled trials with 31,669 heart failure patients found that remote monitoring reduced total HF hospitalizations (incidence rate ratio 0.81, 95% CI 0.72–0.91), first HF hospitalizations (risk ratio 0.82, 95% CI 0.76–0.88), and all-cause mortality (risk ratio 0.90, 95% CI 0.84–0.95) compared with standard care.
Operational and financial returns at the practice level match these clinical gains. Rhythm360 clients have achieved an 80% reduction in critical-alert response times and a 300% increase in revenue through accurate CPT code capture and the addition of new RPM service lines. University of Chicago Medicine (UCM) processed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter, while Gaurav A. Upadhyay, MD, observed, “We have improved billing and accountability for our patients after the integration.”
Andrew Beaser, MD, Associate Professor of Medicine at UCM, highlighted the future direction clearly. “Decision support, including AI-assisted decision support, will become increasingly important as data volumes grow.”
Talk to our team about replicating these results in your practice.
Cardiac-focused patient engagement tools cluster into a few capabilities that consistently move clinical and financial metrics.
The LINK-HF trial demonstrated that continuous remote monitoring with personalized machine-learning models predicted impending HF hospitalizations with 76–88% sensitivity and 85% specificity, providing a median early warning of 6.5 days. For CIED and heart failure populations, practices only reach this level of early detection when a platform unifies multi-OEM data into a single, actionable workspace.
Cardiology practices that implant devices from more than one manufacturer, including Medtronic, Boston Scientific, Abbott, and Biotronik, encounter an immediate operational challenge. Each OEM operates a separate, non-interoperable portal. Staff must log into multiple systems, reconcile conflicting data formats manually, and assemble a complete clinical picture from disconnected sources.
Approximately 70% of patients who qualify for CRT based on current indications respond favorably. EP monitoring typically follows a 91-day cadence, while HF monitoring requires a 31-day rhythm. When combined in a single data stream from CRT devices, manual parsing creates a real risk that clinically relevant HF data remains unreviewed for weeks.
Manual workflows in cardiology practices routinely lose roughly 30% of available RPM revenue to administrative overhead. That revenue leakage compounds across every patient in the panel, every month.
These fragmentation costs become concrete when you examine how unified monitoring changes day-to-day clinical response. The clearest illustration of what a vendor-neutral platform delivers is a scenario that plays out regularly in practices using Rhythm360: a critical arrhythmia flagged on a Saturday morning.
Without a centralized platform, a new-onset atrial fibrillation event transmitted overnight may sit unreviewed until Monday, when a technician logs into the relevant OEM portal during business hours. With Rhythm360 AI-powered alert triage and a HIPAA-compliant mobile application, the on-call clinician receives a prioritized notification regardless of day or time. By Saturday afternoon, the patient is evaluated, anticoagulation is initiated, and a potential stroke is prevented.
Atrial fibrillation was found to be asymptomatic in 27% of participants in a recent study, so many patients who feel well still carry stroke risk. Continuous, reliable monitoring catches those events before they become catastrophic.
Remote cardiac monitoring platforms must meet specific integration and compliance standards, and these capabilities work together as a single system rather than isolated features.
The 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic establishes that effective remote monitoring of CIEDs requires appropriate programming of alerts and comprehensive patient education. Both requirements depend on a platform that filters noise and surfaces only clinically significant events.
Several platforms operate in the cardiac remote monitoring space. The table below outlines how Rhythm360 addresses the capabilities that matter most to cardiology practice administrators and EP lab directors.
| Capability | Rhythm360 | Clinical Relevance | Documented Outcome |
|---|---|---|---|
| Multi-OEM data ingestion | Medtronic, Boston Scientific, Abbott, Biotronik, and others via API, HL7, XML, and computer-vision PDF parsing | Eliminates multiple portal logins and manual data reconciliation | Single source of truth for entire device population |
| AI-powered alert triage | Automated prioritization of clinically significant events, with optional 24/7/365 CCT oversight supervised by physicians | Reduces alert fatigue and surfaces critical arrhythmias and device malfunctions immediately | Up to 80% reduction in critical-alert response times |
| Data transmissibility | >99.9% via redundant data feeds and AI-powered gap extrapolation | Prevents monitoring blind spots during OEM server outages | Supported UCM review of 73,000+ annual reports without data loss |
| Automated CPT code capture | Tracks billable events for 93296, 93297, 93298, 99453, 99454, 99457, 99458 and generates compliant documentation automatically | Closes the 15–30% billable-minute gap caused by fragmented manual tracking | Up to 300% increase in revenue for practices using Rhythm360 |
| HIPAA-compliant mobile access | Secure mobile app for transmission review, report signing, and care coordination from any location | Enables weekend and after-hours critical-event response without workstation dependency | Same-day intervention for Saturday-morning arrhythmia events |
| Bi-directional EHR integration | Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and others via HL7 | Eliminates manual transcription and supports auditable documentation | Enabled the billing accountability improvements documented in the UCM case study |
| Chronic disease service lines | Distinct but integrated Rhythm-CIED and HF/HTN RPM service lines within a single platform | Supports correct 31-day HF and 91-day EP monitoring cadences without manual parsing | New recurring revenue streams from HF and hypertension RPM billing |
Request a walkthrough of these capabilities tailored to your device population and EHR environment.
A unified patient engagement platform in cardiology creates a direct and measurable financial impact. A 500-patient cardiology CCM/RPM program typically captures $300,000 to $500,000 per year in incremental revenue through billing automation, driven by closing the 99457 gap (~$72,000), capturing additional 99458 units (~$117,000), eliminating 99454 denials ($50,000–$70,000), and realizing the 2026 CPT 93296 RVU increase (~$25,600 for a 200-patient CIED program).
Practices implementing patient engagement platforms typically see a 20–40% reduction in no-shows, a 15–25% decrease in administrative costs, a 60% improvement in patient retention, and an average three-year ROI of 6:1 to 15:1.
Rhythm360 connects each of these outcomes to specific capabilities. Automated CPT documentation closes the billing gap. AI triage reduces staff hours required per patient. Bi-directional EHR integration removes manual transcription that drives administrative overhead. Together, these features help practices capture more revenue per patient while reducing the burden on clinical and administrative teams.
Rhythm360 implementation, including EHR integration with systems such as Epic, Cerner, Athenahealth, and eClinicalWorks, typically takes from a few days to a few weeks. Timeline depends on the complexity of the existing infrastructure and the number of OEM device connections required. The onboarding process minimizes disruption to current workflows, and RhythmScience provides dedicated support throughout setup so data connections are validated before go-live.
Rhythm360 operates as a vendor-neutral platform and ingests data from all major cardiac device manufacturers, including Medtronic, Boston Scientific, Abbott, and Biotronik. The platform uses direct APIs, HL7 feeds, XML parsing, and computer vision-powered PDF extraction to capture data regardless of OEM format. A redundant data feed architecture provides a fail-safe if any single OEM server experiences downtime, maintaining greater than 99.9% data transmissibility across the patient population.
Rhythm360 AI-powered alert triage analyzes incoming transmissions and assigns clinical priority based on event type and severity. Routine, non-actionable transmissions are processed and documented automatically without generating a clinician notification. Clinically significant events such as new-onset atrial fibrillation, ventricular tachycardia, lead malfunction, or ERI/RRT indicators are escalated immediately through the notification system.
Practices can also opt into 24/7/365 oversight by certified cardiac technicians (CCTs) supervised by physicians. This additional human review layer supports high-volume environments. The combination of AI triage and expert oversight has produced up to an 80% reduction in critical-alert response times for Rhythm360 clients.
Rhythm360 supports automated documentation and billing tracking for the full range of remote cardiac monitoring and RPM CPT codes. Supported codes include 93296, 93297, 93298, 93299 for CIED remote monitoring and 99453, 99454, 99457, and 99458 for remote physiological monitoring of chronic conditions such as heart failure and hypertension.
The platform tracks each patient’s monitoring activity against the specific thresholds required for each code, including the 16-day transmission requirement for 99454 and the 20-minute management threshold for 99457. It then generates compliant documentation automatically, which reduces claim denials and audit exposure.
Rhythm360 scales across the full spectrum of cardiology providers, from solo electrophysiology practices to large integrated health systems managing thousands of CIED patients. A SaaS-based pricing model adjusts based on clinic size and usage volume, so smaller practices can launch structured remote monitoring programs without enterprise-level capital investment.
The centralized dashboard and automated workflows reduce reliance on a single “super-user” and support business continuity in lean staffing environments.
Cardiology practices managing CIED and chronic heart failure populations face compounding operational, clinical, and financial pressures. Multiple OEM portals do not communicate with each other, alert volumes overwhelm clinical staff, and billing workflows leave significant CPT revenue uncaptured. These challenges represent structural consequences of building a monitoring program on fragmented infrastructure.
Rhythm360 addresses each of these pain points through a single, vendor-neutral, AI-powered platform that ingests multi-OEM data with greater than 99.9% transmissibility, triages alerts by clinical significance, enables HIPAA-compliant mobile access for after-hours response, and automates CPT documentation across the full remote monitoring billing spectrum. Practices that make this transition have documented up to 80% faster critical-alert response and up to 300% revenue growth.
At University of Chicago Medicine, the platform supported review of more than 73,000 reports annually while enabling earlier interventions and improved billing accountability. This outcome reflects what a well-designed patient engagement solution can deliver at scale.
